Services-Medical Laboratories · DE · CIK 1604821
Natera applies proprietary molecular and bioinformatics technology to change disease management worldwide through genetic testing
Comparable business profile · signals at a glance
Coverage (30d): 3 reputable articles.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Mar 20, 2026: 8 sold $123.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 371 | $200.97 | $75K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 280 | $200.90 | $56K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 239 | $198.85 | $48K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 235 | $199.88 | $47K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 235 | $198.49 | $47K |
| Mar 20, 2026 | Sheena JonathanDirector,Other | Sell | 140 | $199.82 | $28K |
| Mar 18, 2026 | Sheena JonathanDirector,Other | Sell | 1,814 | $198.65 | $360K |
| Mar 18, 2026 | Sheena JonathanDirector,Other | Sell | 956 | $197.84 | $189K |
| Mar 18, 2026 | Sheena JonathanDirector,Other | Sell | 300 | $196.27 | $59K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 24,814 | $196.23 | $4.9M |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 16,457 | $197.22 | $3.2M |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 4,875 | $195.42 | $953K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 2,300 | $194.17 | $447K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 900 | $192.43 | $173K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 300 | $190.68 | $57K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 254 | $198.02 | $50K |
| Mar 16, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 100 | $190.07 | $19K |
| Mar 13, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 21,504 | $189.50 | $4.1M |
| Mar 13, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 21,476 | $188.54 | $4.0M |
| Mar 13, 2026 | Rabinowitz MatthewEXECUTIVE CHAIRMAN | Sell | 17,037 | $187.63 | $3.2M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.